Table 4.
Knowledge of the pharmacists towards prescribed medications for dialysis.
| Variables | OP Pharmacist | DC Pharmacist | PP Resident |
|---|---|---|---|
| Oral ciprofloxacin should be administering after dialysis session on dialysis days | |||
| Agree | 35 (77.8) | 8 (88.9) | 11 (91.7) |
| Disagree | 4 (8.9) | 0 (0) | 1 (8.3) |
| Don’t know | 6 (13.3) | 1 (11.1) | 0 (0) |
| Using IV route for epoetin alfa is preferred for hemodialysis patients * | |||
| Agree | 18 (40) | 5 (55.6) | 9 (75) |
| Disagree | 8 (17.8) | 3 (33.3) | 3 (25) |
| Don’t know | 19 (42.2) | 1 (11.1) | 0 (0) |
| The pharmacist should check creatinine clearance for chronic dialysis-dependent patients before dispensing their medications * | |||
| Agree | 36 (80) | 7 (77.8) | 1 (8.3) |
| Disagree | 9 (20) | 2 (22.2) | 10 (83.3) |
| Don’t know | 0 (0) | 0 (0) | 1 (8.3) |
| Augmentin SR can be prescribed for dialysis-dependent patients * | |||
| Agree | 8 (17.8) | 0 (0) | 2 (16.7) |
| Disagree | 28 (62.2) | 9 (100) | 8 (17.8) |
| Don’t know | 9 (20) | 0 (0) | 2 (16.7) |
| Darbepoetin alfa should be used for the reduction or control of serum phosphorous in dialysis-dependent patients * | |||
| Agree | 5 (11.1) | 0 (0) | 0 (0) |
| Disagree | 25 (55.6) | 8 (88.9) | 11 (91.7) |
| Don’t know | 15 (33.3) | 1 (11.1) | 1 (8.3) |
| The maximum meloxicam dose for dialysis-dependent patients is 7.5 mgs per day | |||
| Agree | 41 (91.1) | 7 (77.8) | 10 (83.3) |
| Disagree | 2 (4.4) | 1 (11.1) | 0 (0) |
| Don’t know | 2 (4.4) | 1 (11.1) | 2 (16.7) |
* Significant association between a pharmacist’s place of work and variables (p < 0.05).